Cytokine Gene Polymorphisms in Acute Pancreatitis

Kevin Sargen; Andrew G Demaine; Andrew N Kingsnorth

doi:10.6092/1590-8577/423

Kevin Sargen Departments of Molecular Medicine and Surgery, Plymouth Postgraduate Medical School, Derriford Hospital. Plymouth, United Kingdom
Andrew G Demaine Department of Molecular Medicine, Plymouth Postgraduate Medical School, Derriford Hospital. Plymouth, United Kingdom
Andrew N Kingsnorth Department of Surgery, Plymouth Postgraduate Medical School, Derriford Hospital. Plymouth, United Kingdom

DOI: https://doi.org/10.6092/1590-8577/423

Keywords: Inflammatory Response, Interleukin-10, Tumour Necrosis Factor

Abstract

Context Pro-inflammatory and regulatory cytokines play a key role in the pathogenesis of acute pancreatitis. Genetic loci encoding cytokines have been shown to be polymorphic, in some cases influencing protein expression. Objective To investigate if TNF and IL-10 gene loci are associated with the occurrence or severity of acute pancreatitis. Setting Acute surgical unit within large district hospital serving a population of 500,000. Methods Three TNF microsatellite loci (TNFa, TNFb, TNFc), the TNF-308 polymorphism, the IL-10.G microsatellite locus, and 3 bi-allelic polymorphisms in the IL-10 5’ region were typed using PCR in 135 acute pancreatitis patients and ethnically matched normal controls (n=107). Aetiology of disease was determined and patients grouped according to disease severity by assigning an organ failure score or classification according to the Atlanta system. Main outcome measures Allelic frequency of polymorphic loci in patients with different aetiology and disease course in acute pancreatitis. Results No difference was noted in allelic frequency of any of the cytokine gene loci between groups stratified according to disease severity. When aetiology was studied again there was no significant difference in allelic frequency. Conclusions The cytokine gene polymorphisms studied play no part in determination of disease severity or susceptibility to acute pancreatitis.

Image: Structural formula of Tumor necrosis factor-alpha (TNF-alpha) (Author: Doxepine; Wikimedia Commons)

Downloads

Download data is not yet available.

References

Kingsnorth AN. Role of cytokines and their inhibitors in acute pancreatitis. Gut 1997; 40:1-4.

Kusske AM, Rongione AJ, Reber HA. Cytokines and acute pancreatitis. Gastroenterology 1996; 110:639-42.

Van der Poll T, Van Deventer SJH, Hack CE, Wolbink GJ, Aarden LA, Buller HR, ten Cate JW. Effects on leukocytes following injection of tumor necrosis factor into healthy humans. Blood 1992; 79:693-8.

Van Deventer SJH, Hart M, Van der Poll T, Hack CE, Aarden LA. Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans. J Infect Dis 1993; 167:461-4.

Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, Gukovsky S, Pandol SJ. Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-a. J Clin Invest 1997; 100:1853-62. [AN: 97460013]

Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995; 130:966-70.

Fu K, Sarras MP Jr, De Lisle RC, Andrews GK. Expression of oxidative stress- responsive genes and cytokine genes during cerulein-induced acute pancreatitis. Am J Physiol 1997; 273:G696-705.

Hughes CB, Gaber LW, Mohey el- Din AB, Grewal HP, Kotb M, Mann L, Gaber AO. Inhibition of TNF-a improves survival in an experimental model of acute pancreatitis. Am Surg 1996; 62:8-13.

De Beaux AC, Goldie AS, Ross JA, Carter DC, Fearon KHC. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 1996; 83:349-53.

Norman JG, Fink GW, Messina J, Carter G, Franz MG. Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 1996; 120:515-21.

Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147:3815-22.

Van Laethem J, Marchant A, Delvaux A. Interleukin-10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108:1917-22.

Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, McFadden DW. Interleukin-10 reduces the severity of acute pancreatitis in rats. Gastroenterology 1997; 112:960-7. [AN: 97193674]

Kusske AM, Rongione AJ, Ashley SW. Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery 1996;120:284-9.

Pezzilli R, Billi P, Miniero R, Barakat B. Serum Interleukin-10 in human acute pancreatitis. Dig Dis Sci 1997; 42:1469-72.

Jongeneel CV, Briant L, Udalova IA, Sevin A, Nedaspasov SA, Cambon-Thomsen A. Extensive genetic polymorphism in the human tumour necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci 1991; 88:9717-21. [AN: 92052163]

Wilson AG, de Vries N, Poicot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumour necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177:557-60.

Poicot F, Briant L, Jongeneel CV. Association of tumour necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-a and TNF- b by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23:224-31.

Weissensteiner T, Lanchbury JS. TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics 1997; 47:6-16.

Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996; 110:1053-60. [AN: 96183141]

Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localisation of the mouse and human genes. J Immunol 1992; 146:3618-23.

Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterisation of the 5' flanking sequence. Immunogenetics 1997; 46:120-8. [AN: 97306281]

Kube D, Platzer C, Von Knethen A, Straub H, Bohlen H, Hafner M, Tesch H. Isolation of the human interleukin 10 promoter. Characterisation of the promoter activity in Burkitt's Lymphoma cell lines. Cytokine 1995; 7:1-7.

Eskdale J, Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995; 42:444-5.

Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the Interleukin-10 gene promoter. Eur J Immunogenet 1997; 24:1-8.

Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg 1993; 128:586-90.

Kingsnorth AN, Galloway SW, Formela LJ. Randomised, double-blind phase II trial of Lexipafant, a platelet activating factor antagonist, in human acute pancreatitis. Br J Surg 1995; 82:1414-20.

Nedaspasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. J Immunol 1991; 147:1053-9.

Crouau-Roy B, Briant L, Bouissou C, Stavropoulos C, Poicot F, Cambon-Thomsen A, Clayton J. Tumor necrosis factor microsatellites in four European populations. Hum Immunol 1993; 38:213-6.

Udalova IA, Nedaspasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16:180-6.

Stuber F, Udalova IA, Book M. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996; 46:42-50.